These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 33256676)

  • 1. Effect of sodium-glucose cotransporter-2 inhibitors on aldosterone-to-renin ratio in diabetic patients with hypertension: a retrospective observational study.
    Sawamura T; Karashima S; Nagase S; Nambo H; Shimizu E; Higashitani T; Aono D; Ohbatake A; Kometani M; Demura M; Furukawa K; Takeda Y; Yoneda T
    BMC Endocr Disord; 2020 Nov; 20(1):177. PubMed ID: 33256676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Sodium Glucose Co-Transporter-2 Inhibition on the Aldosterone/Renin Ratio in Type 2 Diabetes Mellitus.
    Griffin TP; Islam MN; Blake L; Bell M; Griffin MD; O'Shea PM
    Horm Metab Res; 2019 Feb; 51(2):91-99. PubMed ID: 30522145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Ramipril on the Aldosterone/Renin Ratio and the Aldosterone/Angiotensin II Ratio in Patients With Primary Aldosteronism.
    Guo Z; Poglitsch M; Cowley D; Domenig O; McWhinney BC; Ungerer JPJ; Wolley M; Stowasser M
    Hypertension; 2020 Aug; 76(2):488-496. PubMed ID: 32507039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between screening for primary aldosteronism with and without drug adjustment.
    Hua Y; He Q
    Blood Press; 2024 May; 33(1):2350981. PubMed ID: 38824645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists on Renin-Angiotensin-Aldosterone System.
    Puglisi S; Rossini A; Poli R; Dughera F; Pia A; Terzolo M; Reimondo G
    Front Endocrinol (Lausanne); 2021; 12():738848. PubMed ID: 34745006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Aldosterone-to-renin ratio threshold for screening primary aldosteronism in Chinese hypertensive patients].
    Chen SX; Du YL; Zhang J; Gong YC; Hu YR; Chu SL; He QB; Song YY; Zhu DL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Oct; 34(10):868-72. PubMed ID: 17217708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-Blocker withdrawal is preferable for accurate interpretation of the aldosterone-renin ratio in chronically treated hypertension.
    Browne GA; Griffin TP; O'Shea PM; Dennedy MC
    Clin Endocrinol (Oxf); 2016 Mar; 84(3):325-31. PubMed ID: 26300226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical relevance of dietary salt intake on aldosterone and the aldosterone-to-renin ratio as screening parameters for primary aldosteronism.
    Koch M; Aker S; Haastert B; Rump LC
    Clin Nephrol; 2010 Sep; 74(3):182-9. PubMed ID: 20860902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Mineralocorticoid and AT1 Receptor Antagonism on The Aldosterone-Renin Ratio In Primary Aldosteronism-the EMIRA Study.
    Rossi GP; Ceolotto G; Rossitto G; Maiolino G; Cesari M; Seccia TM
    J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32067030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of dapagliflozin on renin-angiotensin-aldosterone system under renin-angiotensin system inhibitor administration.
    Isshiki M; Sakuma I; Hayashino Y; Sumita T; Hara K; Takahashi K; Shiojima I; Satoh-Asahara N; Kitazato H; Ito D; Saito D; Hatano M; Ikegami Y; Iida S; Shimada A; Noda M
    Endocr J; 2020 Nov; 67(11):1127-1138. PubMed ID: 32612066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of postural changes on aldosterone to plasma renin ratio in patients with suspected secondary hypertension.
    Barigou M; Ah-Kang F; Orloff E; Amar J; Chamontin B; Bouhanick B
    Ann Cardiol Angeiol (Paris); 2015 Jun; 64(3):169-74. PubMed ID: 26051856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroidomics-Based Screening for Primary Aldosteronism: Impact of antihypertensive Drugs.
    Constantinescu G; Gruber S; Fuld S; Peitzsch M; Schulze M; Remde H; Kürzinger L; Yang J; Yen T; Williams TA; Müller L; Reincke M; Lenders JWM; Beuschlein F; Pamporaki C; Eisenhofer GF
    Hypertension; 2024 Oct; 81(10):2060-2071. PubMed ID: 39082132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of female sex hormones and contraceptive pill on the diagnostic work-up for primary aldosteronism.
    Pizzolo F; Raffaelli R; Memmo A; Chiecchi L; Pavan C; Guarini P; Guidi GC; Franchi M; Corrocher R; Olivieri O
    J Hypertens; 2010 Jan; 28(1):135-42. PubMed ID: 19952782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ratio of serum aldosterone to plasma renin concentration in essential hypertension and primary aldosteronism.
    Trenkel S; Seifarth C; Schobel H; Hahn EG; Hensen J
    Exp Clin Endocrinol Diabetes; 2002 Apr; 110(2):80-5. PubMed ID: 11928071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative Value of Aldosterone-Renin Ratio for Detection of Aldosterone-Producing Adenoma: The Aldosterone-Renin Ratio for Primary Aldosteronism (AQUARR) Study.
    Maiolino G; Rossitto G; Bisogni V; Cesari M; Seccia TM; Plebani M; Rossi GP;
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28529209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Aldosterone/plasma renin activity ratio is a sensitive parameter for screening patients with primary aldosteronism].
    Zhang HL; Liu ZJ; Shao JM; Yan JT; Wang DW
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Oct; 34(10):873-6. PubMed ID: 17217709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].
    Song AL; Zeng ZP; Tong AL; Lu L; Chen S; Li M; Fu CL; Wang YH; Sun ML
    Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):294-8. PubMed ID: 22781950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High efficiency of the aldosterone-to-renin ratio in precisely detecting primary aldosteronism.
    Gan W; Lin W; Ouyang J; Li Y; Chen D; Yao Z; Feng P
    J Hum Hypertens; 2019 Jan; 33(1):57-61. PubMed ID: 30242245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of mineralocorticoid and AT-1 receptor antagonism on the aldosterone-renin ratio (ARR) in primary aldosteronism patients (EMIRA Study): rationale and design.
    Rossitto G; Cesari M; Ceolotto G; Maiolino G; Seccia TM; Rossi GP
    J Hum Hypertens; 2019 Feb; 33(2):167-171. PubMed ID: 30518805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary aldosteronism: Aldosterone/renin ratio cut-off points.
    Eugenio Russmann ML; Delfino L; Fierro F; Santoro S; Peréz M; Caruso G; Glikman P; Gauna A; Lupi S
    Endocrinol Diabetes Nutr (Engl Ed); 2019; 66(6):361-367. PubMed ID: 30737120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.